A pharmaceutical labeling safety signal, or safety change, is an alert that a pharmaceutical company sends to regulatory authorities when there is an undocumented adverse event to its drug. For example, if a drug causes health problems, but that warning isn’t on the drug label, the pharmaceutical company must alert the regulatory authority of the country in which the drug is marketed. The goal is to make the regulatory authority aware of the situation so the drug label can be updated accordingly.